Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Treasury Shares (2021 - 2023)

Historic Treasury Shares for Bolt Biotherapeutics (BOLT) over the last 3 years, with Q4 2023 value amounting to $52533.0.

  • Bolt Biotherapeutics' Treasury Shares fell 5689.32% to $52533.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $52533.0, marking a year-over-year decrease of 5689.32%. This contributed to the annual value of $52533.0 for FY2023, which is 5689.32% down from last year.
  • Bolt Biotherapeutics' Treasury Shares amounted to $52533.0 in Q4 2023, which was down 5689.32% from $121867.0 recorded in Q4 2022.
  • In the past 5 years, Bolt Biotherapeutics' Treasury Shares registered a high of $336000.0 during Q4 2021, and its lowest value of $52533.0 during Q4 2023.
  • For the 3-year period, Bolt Biotherapeutics' Treasury Shares averaged around $170133.3, with its median value being $121867.0 (2022).
  • As far as peak fluctuations go, Bolt Biotherapeutics' Treasury Shares plummeted by 6373.01% in 2022, and later tumbled by 5689.32% in 2023.
  • Bolt Biotherapeutics' Treasury Shares (Quarter) stood at $336000.0 in 2021, then crashed by 63.73% to $121867.0 in 2022, then tumbled by 56.89% to $52533.0 in 2023.
  • Its Treasury Shares was $52533.0 in Q4 2023, compared to $121867.0 in Q4 2022 and $336000.0 in Q4 2021.